Hepatitis E： From behind the scenes to the front stage
10.3969/j.issn.1001-5256.2023.11.001
- VernacularTitle:戊型肝炎：从幕后走到台前
- Author:
Jian WU
1
;
Ze XIANG
2
;
Hongcui CAO
3
Author Information
1. Center of Laboratory Medicine， Suzhou Municipal Hospital， Suzhou， Jiangsu 215008， China
2. Chinese Consortium for the Study of Hepatitis E， Suzhou， Jiangsu 215008， China
3. National Key Laboratory of Diagnosis and Treatment of Severe Infectious Diseases， National Clinical Research Center for Infectious Diseases， Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases， The First Affiliated Hospital， Zhejiang University School of Medicine， Hangzhou 310003， China
- Publication Type:Journal Article
- Keywords:
Hepatitis E;
Public Health;
Diagnosis;
Therapeutics
- From:
Journal of Clinical Hepatology
2023;39(11):2521-2523
- CountryChina
- Language:Chinese
-
Abstract:
Hepatitis E is a type of viral hepatitis caused by hepatitis E virus （HEV） infection. There are four main genotypes of HEV， namely genotypes 1 — 4. Compared with hepatitis B and hepatitis C， previous research on hepatitis E has made slow progress； however， in recent years， hepatitis E has gradually attracted more attention in China， achieving the transition from behind the scenes to the front stage. First， China has a large population base， a large number of people infected with hepatitis E， and a heavy disease burden， and thus it is necessary to attach great importance to the prevention， diagnosis， and treatment of hepatitis E. Second， the World Health Organization （WHO） has put forward the ambitious goal of eliminating viral hepatitis by 2030， and China has made remarkable achievements in the prevention and treatment of hepatitis B and hepatitis C. At present， the incidence and mortality rates of hepatitis E in China have exceeded those of hepatitis A， and the prevention and treatment of hepatitis E in China is of great significance to actively respond to the call of the WHO. Finally， Chinese researchers in the field of hepatitis E have formed Chinese Consortium for the Study of Hepatitis E， formulated related expert consensus， and established international cooperation platforms， which further promotes the research on hepatitis E in China.
